Pharma Microbiology East Coast Conference – A Virtual Conference with Remote Access
pharmaphorum
AUGUST 24, 2020
She served as the Deputy Director (Acting) in the Office of Process and Facilities (OPF)/OPQ/CDER, responsible for new, generic, and biologic drug product quality review and facility assessment. Container Closure Integrity Evaluation: USP Perspective. • Container Closure Integrity Evaluation: USP Perspective. •
Let's personalize your content